ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements with these filters
Indo Borax & Chemicals Ltd has availed funding of ₹225 Crore from a lending institution. The capital will finance its acquisition of equity shares in Kronox Lab Sciences Limited.
Indo Borax & Chemicals reported postal ballot results where shareholders approved borrowing limits up to Rs 400 Crore. One special resolution passed with 98.05% in favour.
Indo Borax reported robust Q1 FY27 results with 31% revenue growth and 59% PAT growth. Management announced a major acquisition of 64.26% stake in Kronox Lab Sciences to diversify into high-purity specialty chemicals.
Indo Borax reported strong Q1FY27 consolidated performance with Revenue up 31% and PAT up 59% YoY. Strategy focuses on high-margin DOT expansion and the acquisition of Kronox Lab Sciences.
Indo Borax & Chemicals Ltd reported revenue from operations of ₹70.4 Cr (+31.3% YoY) and net profit of ₹16.3 Cr (+59.8% YoY) for Q1 FY27.
Indo Borax & Chemicals Limited transcript for Q4 and FY26. Management reports significant transformation under new ownership by Zenrock Chemicals, achieving record revenue growth with a focus on operational efficiency and boron chemistry expansion.
Indo Borax delivered solid FY26 performance with consolidated revenue of ₹215.45 Cr and PAT of ₹50.27 Cr, following a major 50.80% ownership transition to institutional investors.
Indo Borax & Chemicals Ltd reported revenue from operations of ₹63 Cr (+25.7% YoY) and net profit of ₹14.5 Cr (+42.2% YoY) for Q4 FY26.